Skip to content
Clinical Trials – home
European Organisation For Research And Treatment Of Cancer
Sponsor

European Organisation For Research And Treatment Of Cancer

Belgium Emmanuel Mounierlaan 83 Bus 11, 1200 Woluwe-Saint-Lambert, Belgium

About the sponsor

Clinical research includes metastatic hormone-sensitive prostate cancer, castration-resistant prostate cancer, high-risk localized prostate cancer, and metastatic disease to bone, with interest in androgen deprivation therapy, anti-androgen agents, GnRH antagonists, and treatment strategies linked to PSA response and disease control.

  • Hormone therapy
  • Androgen receptor pathway inhibition
  • Bone-metastatic disease

Research also extends to symptom management during endocrine treatment and combinations with radiotherapy or radiopharmaceuticals.

About Specializations

European Organisation For Research And Treatment Of Cancer runs clinical trials in conditions such as Hormone-dependent prostate cancer, Squamous cell carcinoma of head and neck, Hormone receptor positive HER2 negative breast cancer, Astrocytoma malignant, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

23 clinical trials

Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Vorasidenib
  • Sponsor:European Organisation For Research And Treatment Of Cancer
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Lutetium (177Lu) Vipivotide Tetraxetan
  • Sponsor:European Organisation For Research And Treatment Of Cancer
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone
  • Sponsor:European Organisation For Research And Treatment Of Cancer
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:European Organisation For Research And Treatment Of Cancer
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Tebentafusp
  • Sponsor:European Organisation For Research And Treatment Of Cancer
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:European Organisation For Research And Treatment Of Cancer
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Sponsor:European Organisation For Research And Treatment Of Cancer
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:European Organisation For Research And Treatment Of Cancer
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Dacarbazine
  • Sponsor:European Organisation For Research And Treatment Of Cancer
Countries:CyprusCyprus
  • Participants:18–64 years · 65+ years
  • Substances:Duloxetine
  • Sponsor:European Organisation For Research And Treatment Of Cancer
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Degarelix
  • Sponsor:European Organisation For Research And Treatment Of Cancer
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Ipilimumab
  • Sponsor:European Organisation For Research And Treatment Of Cancer

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.